MENQUADFI Injectable Solution
How to use MENQUADFI Injectable Solution
Translated with AI
This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.
Show originalContents of the leaflet
Introduction
Package Leaflet: Information for the User
MenQuadfi, injectable solution
Meningococcal conjugate vaccine against groups A, C, W, and Y
Read all of this leaflet carefully before you or your child receive this medicine, because it contains important information for you or your child.
- Keep this leaflet, you may need to read it again.
- If you have any further questions, ask your doctor, pharmacist, or nurse.
- This medicine has been prescribed for you or your child only. Do not pass it on to others.
- If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if they are not listed in this leaflet. See section 4.
Contents of the package leaflet
- What is MenQuadfi and what is it used for
- What you need to know before you or your child receive MenQuadfi
- How to use MenQuadfi
- Possible side effects
- Storage of MenQuadfi
- Contents of the pack and further information
1. What is MenQuadfi and what is it used for
MenQuadfi (MenACWY) is a vaccine that can be administered to children from 1 year of age, adolescents, and adults.
MenQuadfi helps protect against infections caused by a type of bacteria (germs) called Neisseria meningitidis, specifically against types A, C, W, and Y.
The bacteria Neisseria meningitidis(also called meningococcus) can be transmitted from person to person and can cause serious and sometimes potentially life-threatening infections, such as:
- Meningitis - an inflammation of the tissues that surround the brain and spinal cord;
- Septicemia - a blood infection.
Both infections can cause severe illness with long-term effects or possibly death.
MenQuadfi should be used in accordance with official national recommendations.
How the vaccine works
MenQuadfi works by stimulating the body's natural defense (immune system) to produce protective antibodies against the bacteria.
MenQuadfi only helps protect against diseases caused by Neisseria meningitidisof types A, C, W, and Y.
- It does not protect against infections caused by other types of Neisseria meningitidis.
- It does not protect against meningitis or septicemia caused by other bacteria or viruses.
2. What you need to know before receiving MenQuadfi
Do not use MenQuadfi if you or your child
- are allergic to any of the active substances or any of the other ingredients of this vaccine (listed in section 6) or have had a previous allergic reaction to this vaccine.
If you are not sure, consult your doctor, pharmacist, or nurse before you or your child receive MenQuadfi.
Warnings and precautions
Consult your doctor, pharmacist, or nurse before vaccination with MenQuadfi if you or your child have any of the following conditions:
- a high fever infection (over 38 °C). If this occurs, the vaccine will be administered after the infection is under control. There is no need to delay vaccination in the case of a minor infection such as a cold. However, consult your doctor, pharmacist, or nurse first.
- a bleeding problem or bruise easily.
- have fainted in the past due to an injection. Fainting can occur after or even before any injection, sometimes accompanied by falls (mainly in adolescents).
- a weakened immune system (e.g., due to HIV infection, another disease, or use of a medicine that affects the immune system), as you or your child may not fully benefit from receiving MenQuadfi.
If any of the above applies to you or your child (or if you are not sure if it applies), consult your doctor, pharmacist, or nurse before you or your child receive MenQuadfi.
As with any vaccine, vaccination with MenQuadfi may not protect all vaccinated individuals.
Other medicines and MenQuadfi
Consult your doctor, pharmacist, or nurse if you or your child are using, have recently used, or might use another vaccine or medicine, including those obtained without a prescription.
In particular, consult your doctor, pharmacist, or nurse if you or your child are taking any medicine that affects your immune system, such as:
- high-dose corticosteroids
- chemotherapy
MenQuadfi can be administered at the same time as other vaccines at separate injection sites during the same visit. These include vaccines against measles, mumps, rubella, varicella, diphtheria, tetanus, pertussis, polio, Haemophilus influenzaetype b, hepatitis B, pneumococcal infections, human papillomavirus, and Neisseria meningitidistype B.
Pregnancy and breast-feeding
If you are pregnant or breast-feeding, think you may be pregnant, or are planning to have a baby, consult your doctor, pharmacist, or nurse before receiving MenQuadfi.
Driving and using machines
MenQuadfi is unlikely to affect your ability to drive, ride a bicycle, or use machines. However, do not drive, ride a bicycle, or use machines if you do not feel well.
MenQuadfi contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per dose; this is essentially "sodium-free".
3. How to use MenQuadfi
MenQuadfi is administered by a doctor or nurse as a 0.5 ml injection into the muscle. It is administered in the upper arm or thigh, depending on age and muscle mass.
4. Possible side effects
Like all vaccines, MenQuadfi can cause side effects, although not everybody gets them.
If you or your child experience any of the following symptoms after vaccination:
- skin rash with itching
- difficulty breathing, shortness of breath
- swelling of the face, lips, throat, or tongue
Seek medical attention immediately or go to the emergency department of the nearest hospital. These may be signs of an allergic reaction.
Side effects in children (from 2 years of age), adolescents, and adults
Very common(may affect more than 1 in 10 people)
- pain at the injection site
- muscle pain
- headache
- feeling unwell
Common(may affect up to 1 in 10 people)
- redness or swelling at the injection site
- fever
Uncommon(may affect up to 1 in 100 people)
- itching, warmth, bruising, or redness at the injection site
- vomiting
- dizziness
- nausea
- fatigue (feeling tired)
Rare(may affect up to 1 in 1,000 people)
- enlarged lymph nodes
- diarrhea
- stomach pain
- urticaria
- itching
- skin rash
- arm or leg pain
- chills
- armpit pain
- hardening at the injection site
Very rare(may affect less than 1 in 10,000 people)
- severe and sudden allergic reactions with difficulty breathing, urticaria, swelling of the face and throat, rapid heartbeat, dizziness, weakness, sweating, and loss of consciousness
Frequency not known(cannot be estimated from the available data)
- allergic reactions
- seizures with or without fever
Side effects in children from 12 to 23 months
Very common(may affect more than 1 in 10 people)
- sensitivity/pain, redness, or swelling at the injection site
- irritability
- crying
- loss of appetite
- sleepiness
Common(may affect up to 1 in 10 people)
- fever
- vomiting
- diarrhea
Uncommon(may affect up to 1 in 100 people)
- difficulty sleeping
- urticaria
- itching, bruising, or redness at the injection site
Very rare(may affect less than 1 in 10,000 people)
- severe and sudden allergic reactions with difficulty breathing, urticaria, swelling of the face and throat, rapid heartbeat, dizziness, weakness, sweating, and loss of consciousness
Frequency not known(cannot be estimated from the available data)
- allergic reactions
- seizures with or without fever
Reporting of side effects
If you or your child experience any side effects, talk to your doctor, pharmacist, or nurse, even if they are not listed in this leaflet. You can also report side effects directly through the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.
5. Storage of MenQuadfi
Keep this vaccine out of the sight and reach of children.
Do not use this vaccine after the expiry date which is stated on the carton after EXP. The expiry date is the last day of the month stated.
Store in a refrigerator (between 2 °C and 8 °C).
Do not freeze.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
6. Contents of the pack and further information
Composition of MenQuadfi
One dose (0.5 ml) contains:
- The active substances are:
- Neisseria meningitidisgroup A polysaccharide 10 micrograms
- Neisseria meningitidisgroup C polysaccharide 10 micrograms
- Neisseria meningitidisgroup Y polysaccharide 10 micrograms
- Neisseria meningitidisgroup W polysaccharide 10 micrograms
- Conjugated with tetanus toxoid carrier protein 55 micrograms
- The other excipients are:
- sodium chloride
- sodium acetate (E 262)
- water for injections
Appearance and pack contents
MenQuadfi is a clear and colorless injectable solution.
MenQuadfi is available in packs of 1, 5, or 10 single-dose vials (0.5 ml) and in a pack of 1 single-dose vial (0.5 ml) co-packaged with 1 empty syringe for single use and 2 needles.
Not all pack sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder
Sanofi Winthrop Industrie
82 Avenue Raspail
94250 Gentilly
France
Manufacturer
Sanofi Winthrop Industrie
Voie de l’Institut
Parc Industriel d’Incarville
BP 101
27100 Val de Reuil
France
Sanofi-Aventis Zrt.
Building DC5
Campona utca 1.
Budapest, 1225
Hungary
You can request more information about this medicine from the local representative of the marketing authorization holder:
België/Belgique/Belgien Sanofi Belgium Tel: +32 2 710.54.00 | Lietuva Swixx Biopharma UAB Tel: +370 5 236 91 40 |
| Luxembourg/Luxemburg Sanofi Belgium Tel: +32 2 710.54.00 |
Ceská republika Sanofi s.r.o. Tel: +420 233 086 111 | Magyarország sanofi-aventis zrt Tel.: +36 1 505 0055 |
Danmark Sanofi A/S Tlf.: +45 4516 7000 | Malta Sanofi S.r.l. Tel: +39 02 39394275 |
Deutschland Sanofi-Aventis Deutschland GmbH Tel: 0800 54 54 010 Tel from abroad: +49 69 305 21 130 | Nederland Sanofi B.V. Tel: +31 20 245 4000 |
Eesti Swixx Biopharma OÜ Tel: +372 640 10 30 | Norge Sanofi-aventis Norge AS Tlf: + 47 67 10 71 00 |
Ελλáδα ΒΙΑΝΕΞ Α.Ε. Τηλ: +30.210.8009111 | Österreich Sanofi-Aventis GmbH Tel: +43 (1) 80185-0. |
España sanofi-aventis, S.A. Tel: +34 93 485 94 00 | Polska Sanofi Sp. z o.o. Tel.: +48 22 280 00 00 |
France Sanofi Winthrop Industrie Tel: 0800 222 555 Call from abroad: +33 1 57 63 23 23 | Portugal Sanofi – Produtos Farmacêuticos, Lda. Tel: + 351 21 35 89 400 |
Hrvatska Swixx Biopharma d.o.o Tel: +385 1 2078 500 Ireland sanofi-aventis Ireland T/A SANOFI Tel: + 353 (0) 1 4035 600 | România Sanofi Romania SRL Tel: +40(21) 317 31 36 Slovenija Swixx Biopharma d.o.o. Tel: +386 1 235 51 00 |
Ísland Vistor Sími: +354 535 7000 | Slovenská republika Swixx Biopharma s.r.o. Tel: +421 2 208 33 600 |
Italia Sanofi S.r.l. Tel: 800536389 | Suomi/Finland Sanofi Oy Puh/Tel: +358 (0) 201 200 300 |
Κúπρος C.A. Papaellinas Ltd. Τηλ: +357 22 741741 | Sverige Sanofi AB Tel: +46 8-634 50 00 |
Latvija Swixx Biopharma SIA Tel: +371 6 616 47 50 |
Date of last revision of this leaflet:
Other sources of information
Detailed information on this medicine is available on the European Medicines Agency website: https://www.ema.europa.eu
- Country of registration
- Active substance
- Prescription requiredYes
- Manufacturer
- This information is for reference only and does not constitute medical advice. Always consult a doctor before taking any medication. Oladoctor is not responsible for medical decisions based on this content.
- Alternatives to MENQUADFI Injectable SolutionDosage form: INJECTABLE, 0.5 mlManufacturer: Sanofi Winthrop IndustriePrescription requiredDosage form: INJECTABLE, 0.5 mlManufacturer: Sanofi Winthrop IndustriePrescription requiredDosage form: INJECTABLE, -Manufacturer: Glaxosmithkline Vaccines S.R.L.Prescription required
Online doctors for MENQUADFI Injectable Solution
Discuss questions about MENQUADFI Injectable Solution, including use, safety considerations and prescription review, subject to medical assessment and local regulations.
Frequently Asked Questions
